These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12007524)

  • 41. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
    Yoshihara S; Fukuda H; Arisaka O
    Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of the tetrodotoxin-resistant sodium channel (PN3/SNS): a possible new treatment for bladder pain.
    Yoshimura N; Seki S; Erickson V; Erickson K; Kassotakis L; Novakovic S; Fraser MO; Chancellor MB; de Groat WC
    Urology; 2001 Jun; 57(6 Suppl 1):116-7. PubMed ID: 11378093
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effects of suplatast tosilate (IPD-1151T) on antibody formations in mice].
    Matsuura N; Mori H; Nagai H; Koda A
    Nihon Yakurigaku Zasshi; 1992 Dec; 100(6):485-93. PubMed ID: 1336470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate.
    Shirai T; Hashimoto D; Suzuki K; Osawa S; Aonahata M; Chida K; Nakamura H
    J Allergy Clin Immunol; 2001 May; 107(5):924-5. PubMed ID: 11344364
    [No Abstract]   [Full Text] [Related]  

  • 45. Response of hypogastric afferent fibers to bladder distention or irritation in cats.
    Guo W; Shapiro K; Wang Z; Pace N; Cai H; Shen B; Wang J; de Groat WC; Tai C; Beckel JM
    Exp Neurol; 2020 Jul; 329():113301. PubMed ID: 32251646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Afferent mechanism in the urinary tract.
    Kanai AJ
    Handb Exp Pharmacol; 2011; (202):171-205. PubMed ID: 21290227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.
    Yoshimura N; Oguchi T; Yokoyama H; Funahashi Y; Yoshikawa S; Sugino Y; Kawamorita N; Kashyap MP; Chancellor MB; Tyagi P; Ogawa T
    Int J Urol; 2014 Apr; 21 Suppl 1(0 1):18-25. PubMed ID: 24807488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacologic perspective on the physiology of the lower urinary tract.
    Andersson KE; Hedlund P
    Urology; 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1. PubMed ID: 12493344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IPD-1151T: a prototype drug for IgE antibody synthesis modulation.
    Koda A; Yanagihara Y; Matsuura N
    Agents Actions Suppl; 1991; 34():369-78. PubMed ID: 1665310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Successful treatment of chronic eosinophilic pneumonia with suplatast tosilate].
    Kusumoto H; Mizuno K; Yonemaru M; Nakano M; Ichinose Y; Toyama K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 May; 35(5):550-4. PubMed ID: 9234634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of suplatast tosilate (IPD) with chloride channels in human blood eosinophils: a potential mechanism underlying its anti-allergic and anti-asthmatic effects.
    Agrawal DK; Cheng G; Kim MJ; Kiniwa M
    Clin Exp Allergy; 2008 Feb; 38(2):305-12. PubMed ID: 18028459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of hyperpolarization-activated current (Ih) in dorsal root ganglion neurons innervating rat urinary bladder.
    Masuda N; Hayashi Y; Matsuyoshi H; Chancellor MB; de Groat WC; Yoshimura N
    Brain Res; 2006 Jun; 1096(1):40-52. PubMed ID: 16765328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Afferent fibers of the hypogastric nerves are involved in the facilitating effects of chemical bladder irritation in rats.
    Mitsui T; Kakizaki H; Matsuura S; Ameda K; Yoshioka M; Koyanagi T
    J Neurophysiol; 2001 Nov; 86(5):2276-84. PubMed ID: 11698518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of IPD-1151T (Suplatast Tosilate) on airway hyperresponsiveness in mice.
    Konno S; Asano K; Gonokami Y; Kurokawa M; Kawazu K; Adachi M
    Arerugi; 1995 May; 44(5):556-61. PubMed ID: 7619009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antigenicity tests of suplatast tosilate (IPD-1151T)].
    Kouchi Y; Ohuchida A; Maeda Y; Katayama S; Kurokawa M; Mizumoto T; Nakagawa M; Manabe H; Sugimoto S; Yoshida R
    J Toxicol Sci; 1992 May; 17 Suppl 2():221-33. PubMed ID: 1321263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DMSO: effect on bladder afferent neurons and nitric oxide release.
    Birder LA; Kanai AJ; de Groat WC
    J Urol; 1997 Nov; 158(5):1989-95. PubMed ID: 9334655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
    Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
    Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The T-type calcium channel Ca V 3.2 regulates bladder afferent responses to mechanical stimuli.
    Grundy L; Tay C; Christie S; Harrington AM; Castro J; Cardoso FC; Lewis RJ; Zagorodnyuk V; Brierley SM
    Pain; 2023 May; 164(5):1012-1026. PubMed ID: 36279179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Reproductive and developmental toxicity study of suplatast tosilate (IPD-1151T) (1)--Fertility study in rats by oral administration].
    Aso S; Sueta S; Kajiwara Y; Morita S; Horiwaki S; Yamakita O
    J Toxicol Sci; 1992 May; 17 Suppl 2():141-54. PubMed ID: 1321258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate].
    Yamasawa H; Oshikawa K; Sugiyama Y
    Arerugi; 2001 Jun; 50(6):513-9. PubMed ID: 11517513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.